Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Indonesia

Indonesia separates regulatory approval, HTA and formulary decisions, payment conditions, procurement and actual patient use.

BPOM and eligible registrant

Patient, payer and care provider

HTA Committee, assessment agency and Ministry of Health

Eligible proposing institutions and Ministry of Health

Ministry of Health, BPJS Kesehatan and provider

8 decision nodes17 cited sources

For education only — not regulatory, pricing or legal advice.